Risk factors for bone mineral density loss in pediatric renal transplant patients

E N Ellis1, D M Floyd-Gimon, P L Berry

  • 1Department of Pediatrics, University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock 72202, USA. EllisEileenN@exchange.UAMS.edu

Insights

Pediatric renal transplant recipients often experience decreased bone mineral density (BMD). Key risk factors include adolescence, longer time post-transplant, and corticosteroid use, necessitating further research and intervention strategies.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Bone Metabolism

Background:

  • Bone mineral density (BMD) is reduced in pediatric renal transplant recipients.
  • Understanding risk factors for BMD loss is crucial for long-term patient health.

Purpose of the Study:

  • To identify risk factors associated with decreased BMD in children and adolescents following renal transplantation.

Main Methods:

  • Dual-energy X-ray absorptiometry (DEXA) was used to assess BMD in 33 pediatric patients (aged 7-22 years).
  • Data collected included age, weight, Tanner stage, dialysis history, and medication dosages (corticosteroids, cyclosporin A).

Main Results:

  • A significant percentage of patients exhibited low BMD Z-scores (45% spine, 42% femur).
  • Decreased BMD correlated inversely with increasing age, time post-transplant, and advanced Tanner stages (pubertal development).
  • Cumulative corticosteroid dose was linked to lower total body BMD; ethnicity also played a role.

Conclusions:

  • BMD deficits in pediatric renal transplant patients emerge during adolescence.
  • Risk factors for BMD loss include age, time since transplant, pubertal stage, and ethnicity.
  • Longitudinal studies and therapeutic strategies are recommended to improve BMD in this population.

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...